Shattuck Labs develops antibody treatments for inflammatory and immune diseases, led by its DR3 blocking candidate SL-325. It last closed at $4.46 on Nov 20, down 1.98% on the day. The next earnings report for STTK is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, STTK reported EPS of -$0.14 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 8 reports the stock moved an average of 5.7% the session after earnings. Over the last 12 months STTK insiders bought $250K of stock on the open market and sold $592K, according to SEC Form 4 filings.
AI Auto Pilots
Is STTK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold STTK.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on STTKStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
STTK · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 13% below its 20 day and 26% below its 50 day average. It is 36% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the swing low (Nov 6) at $4.38, and the nearest resistance the Pivot at $4.52.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 8.3%/day
Key levels
$8.3352 week high+86.8%
$6.36100 day average+42.6%
$6.09200 day average+36.5%
$5.6150 day average+25.8%
$5.10Swing high (Jun 15)+14.3%
$5.0320 day average+12.8%
$4.62Pivot R1+3.6%
$4.52Pivot+1.3%
$4.46Last close
$4.38Swing low (Nov 6)−1.8%
$4.36Pivot S1−2.2%
$1.8852 week low−57.8%
Indicators
RSI (14)
35.50
Weak, oversold below 30
Neutral
MACD
-0.34
Below its signal line
Bearish
Stochastic
11.2
Near the bottom of its range
Oversold
ADX (14)
22.6
Weak trend
Williams %R
-91.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-84.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.5%
Change over 10 sessions
Bearish
ATR (14)
$0.37
Typical daily range, 8.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 20.9%/day
Key levels
$8.3352 week high+86.8%
$6.36100 day average+42.6%
$6.09200 day average+36.5%
$5.6150 day average+25.8%
$5.10Swing high (Jun 15)+14.3%
$5.0320 day average+12.8%
$4.62Pivot R1+3.6%
$4.52Pivot+1.3%
$4.46Last close
$4.38Swing low (Nov 6)−1.8%
$4.36Pivot S1−2.2%
$1.8852 week low−57.8%
Indicators
RSI (14)
36.45
Weak, oversold below 30
Neutral
MACD
-0.29
Below its signal line
Bearish
Stochastic
5.6
Near the bottom of its range
Oversold
ADX (14)
18.3
No clear trend
Williams %R
-96.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-152.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−28.1%
Change over 10 sessions
Bearish
ATR (14)
$0.93
Typical daily range, 20.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for STTK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how STTK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow STTK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for STTKHow many large options trades hit STTK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in STTK in the last 90 days.
From SEC Form 4 filings by STTK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STTK is in one of them and how their past STTK trades turned out.
Shattuck Labs is a biotechnology company based in Austin, Texas, that develops antibody treatments for inflammatory and immune diseases. Its lead candidate, SL-325, is designed to block the DR3 receptor, the only known receptor for the immune signaling molecule TL1A. The company is testing SL-325 in early clinical trials, with a planned focus on inflammatory bowel disease, and is also developing related antibodies. Its intended patients are people living with these conditions.